The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final results and preliminary correlative analysis of a phase I study of anetumab ravtansine in combination with checkpoint inhibitors and gemcitabine in mesothelin-positive advanced pancreatic adenocarcinoma (NCI10208).
 
Carlos Diego Lopes
No Relationships to Disclose
 
Anup Kasi
Consulting or Advisory Role - Cardinal Health; Ipsen; Partner Therapeutics
Research Funding - Ability Pharma (Inst); Boundless Bio (Inst); Cardiff Oncology (Inst); Cend Therapeutics (Inst); FibroGen (Inst); Geistlich Pharma (Inst); Medlink (Inst); Novita Pharmaceuticals (Inst); Novocure (Inst); Seattle Genetics/Astellas (Inst)
 
Laith Abushahin
Research Funding - Celgene (Inst)
 
Dana Cardin
Honoraria - OncLive/MJH Life Sciences
Consulting or Advisory Role - Sago; the KOL Connection Ltd
Research Funding - Arcus Biosciences (Inst); Elicio Therapeutics (Inst); Lilly (Inst); Novartis (Inst); XBiotech (Inst)
Travel, Accommodations, Expenses - Arcus Biosciences
Other Relationship - UpToDate
 
Heinz-Josef Lenz
Honoraria - Abbvie; Adagene; Bayer; Boehringer Ingelheim; Fulgent Genetics; Janssen Oncology; Jazz Pharmaceuticals; Merck Serono; Merus; Roche
Consulting or Advisory Role - 3T BioSciences; Abbvie; Adagene; Bayer; BMS; Fulgent Genetics; GlaxoSmithKline; Merck Serono; Roche
Travel, Accommodations, Expenses - Bayer; BMS; Merck Serono
 
Farshid Dayyani
Consulting or Advisory Role - AstraZeneca; Eisai; Jazz Pharmaceuticals
Speakers' Bureau - Astellas Pharma; beone; ipsen; Sirtex Medical; Takeda
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst); Exelixis (Inst); Genentech (Inst); Ipsen (Inst); Merck (Inst); Taiho Pharmaceutical (Inst)
 
Wells Messersmith
Honoraria - Research to Practice (Inst)
Consulting or Advisory Role - Amgen; Criterium (Inst)
Research Funding - Accent Therapeutics; Agenus (Inst); ALX Oncology (Inst); AstraZeneca/MedImmune (I); Exelixis (Inst); Experimental Drug Development Centre (EDDC); Nurix (Inst); Pfizer (Inst); RasCal (Inst); Revolution Medicines (Inst)
 
Nkiruka Ezenwajiaku
No Relationships to Disclose
 
Paul Oberstein
Consulting or Advisory Role - Boehringer Ingelheim; Ipsen; Janssen Oncology; Jazz Pharmaceuticals; Loxo/Lilly; Revolution Medicines
Speakers' Bureau - Ipsen; Jazz Pharmaceuticals
Research Funding - Amal Therapeutics (Inst); Arcus Biosciences (Inst); Loxo/Lilly (Inst); Merck (Inst); Novartis (Inst); Revolution Medicines (Inst); Roche/Genentech (Inst)
Expert Testimony - Merck
 
Ravi Paluri
Honoraria - Exelixis; Ipsen; Seagen
Consulting or Advisory Role - Exelixis
Speakers' Bureau - Exelixis; Ipsen
Research Funding - Geistlich Pharma; Minneamrita Therapeutics; Seagen
 
Reema Patel
No Relationships to Disclose
 
Kathleen Pfaff
Employment - Dana-Farber Cancer Institute
Patents, Royalties, Other Intellectual Property - receive royalties for patent on a high content screening assay for iPSC-derived motor neuron survival (work done prior to joining DFCI)
 
Edward Kim
No Relationships to Disclose
 
Aparna Kalyan
Honoraria - Samumed
Consulting or Advisory Role - AstraZeneca; Boston Scientific; BTG; Elevar Therapeutics; Exelixis; Genentech; Incyte
Speakers' Bureau - AstraZeneca; Boston Scientific; Exelixis; Genentech/Roche
Research Funding - AstraZeneca (Inst); Bristol-Myers Squibb (Inst)
 
Brandon Smaglo
Consulting or Advisory Role - Ipsen; Syros Pharmaceuticals
Research Funding - AstraZeneca; Merck
(OPTIONAL) Uncompensated Relationships - Ipsen
 
Manik Amin
No Relationships to Disclose
 
Mohammed Al Hallak
Consulting or Advisory Role - Pfizer
Speakers' Bureau - Astellas Pharma; AstraZeneca; Exelixis; Guardant Health; Incyte; Pfizer; Takeda
 
Olumide Gbolahan
Consulting or Advisory Role - Astellas Pharma; AstraZeneca; Boston Scientific; Cardinal Health; Curio Science; Incyte; Lantheus Medical Imaging; Merus
Research Funding - Astellas Pharma (Inst); AstraZeneca/MedImmune (Inst); Bayer (Inst); Eisai (Inst); Elicio Therapeutics (Inst); EMD Serono (Inst); Jazz Pharmaceuticals (Inst); Merus (Inst); Relay Therapeutics (Inst); Roche/Genentech (Inst); Seagen (Inst)
 
Helen Chen
No Relationships to Disclose
 
Anna Spreafico
Consulting or Advisory Role - BeiGene; Bristol-Myers Squibb; GlaxoSmithKline; Merck
Research Funding - Alentis Therapeutics (Inst); Alkermes (Inst); ALX Oncology (Inst); Amgen (Inst); Array BioPharma (Inst); AstraZeneca/MedImmune (Inst); Bristol-Myers Squibb (Inst); Genentech (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Incyte (Inst); Merck (Inst); Novartis (Inst); Pfizer (Inst); Replimune (Inst); Roche (Inst); Seagen (Inst); SERVIER (Inst); Symphogen (Inst); Teva (Inst); Treadwell Therapeutics (Inst)